Yes, the discussion here is getting interesting again.
I also agree that now is a good time for investing in biotechs. In addition to the potential the entire has over the coming years, as you have pointed out, I think that there is anopther, less tangible return. Namely, the biotech industry is attempting to bring products to market for unmet medical needs, or to futher improve upon existing medical treatments. In this way, their products improve the quality and length of life. I don't mind investing in a several companies on the hope that one day, maybe just one of these small companies may find new treatments for heart disease, cancer, and the like.
At some point I remember we had discussed ATIS as being at the forefront of tissue engineering. Whether tissue engineering will become fact or will remain fantasy, who knows at this time? Some day, it is believed my many experts that many of the approaches being investigated today (and engineered human skin is just the tip of the iceberg) will ultimately become prodcuts. ATIS should be well-placed in this case to be an industry leader.
Rick C |
